 Through CHAI, Singh has overseen the distribution of millions of dollars in anti-malaria supplies and equipment.CHAI also works to enable longer-term development and licensing of anti-malarial drugs.In 2008, Singh gained note for negotiating a licensing agreement to allow the production of artemisinin, a key anti-malarial ingredient, at 70% below the then-current market price.